2009-03-30 13:43 Anticancer Research has, in its latest issue, published results from a successful preclinical study on a new formulation of the cancer therapeutic drug cisplatin. The study has been conducted by Optovent, subsidiary to Accelerator Nordic AB, together with scientists at Karolinska Institute and Heidelberg University.

2009-03-30 13:35 Tidskriften Anticancer research har i sitt senaste nummer publicerat resultaten från en framgångsrik preklinisk studie kring cancerbehandling med inkapslat cellgift. Studien har genomförts av Accelerators dotterbolag Optovent AB, tillsammans med forskare vid Karolinska Institutet och Heidelberg universitet.